Skip to main content
Top
Published in: Osteoporosis International 6/2015

01-06-2015 | Original Article

Bone marrow fat is increased in chronic kidney disease by magnetic resonance spectroscopy

Authors: R. N. Moorthi, W. Fadel, G. J. Eckert, K. Ponsler-Sipes, S. M. Moe, C. Lin

Published in: Osteoporosis International | Issue 6/2015

Login to get access

Abstract

Summary

In aging, the bone marrow fills with fat and this may lead to higher fracture risk. We show that a bone marrow fat measurement by magnetic resonance spectroscopy (MRS), a newer technique not previously studied in chronic kidney disease (CKD), is useful and reproducible. CKD patients have significantly higher bone marrow fat than healthy adults.

Introduction

Renal osteodystrophy leads to increased morbidity and mortality in patients with CKD. Traditional bone biopsy histomorphometry is used to study abnormalities in CKD, but the bone marrow, the source of osteoblasts, has not been well characterized in patients with CKD.

Methods

To determine the repeatability of bone marrow fat fraction assessment by MRS and water-fat imaging (WFI) at four sites in patients with CKD, testing was performed to determine the coefficients of reproducibility and intraclass coefficients (ICCs). We further determined if this noninvasive technique could be used to determine if there are differences in the percent bone marrow fat in patients with CKD compared to matched controls using paired t tests.

Results

The mean age of subjects with CKD was 59.8 ± 7.2 years, and the mean eGFR was 24 ± 8 ml/min. MRS showed good reproducibility at all sites in subjects with CKD and controls, with a coefficient of reproducibilities ranging from 2.4 to 13 %. MRS and WFI assessment of bone marrow fat showed moderate to strong agreement (ICC 0.6–0.7) at the lumbar spine, with poorer agreement at the iliac crest and no agreement at the tibia. The mean percent bone marrow fat at L2–L4 was 13.8 % (95 % CI 8.3–19.7) higher in CKD versus controls (p < 0.05).

Conclusions

MRS is a useful and reproducible technique to study bone marrow fat in CKD. Patients with CKD have significantly higher bone marrow fat than healthy adults; the relationship with bone changes requires further analyses.
Literature
1.
3.
go back to reference Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G, Kidney Disease: Improving Global O (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69(11):1945–1953. doi:10.1038/sj.ki.5000414 PubMedCrossRef Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G, Kidney Disease: Improving Global O (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69(11):1945–1953. doi:10.​1038/​sj.​ki.​5000414 PubMedCrossRef
4.
go back to reference Piraino B, Chen T, Cooperstein L, Segre G, Puschett J (1988) Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol 30(2):57–62PubMed Piraino B, Chen T, Cooperstein L, Segre G, Puschett J (1988) Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol 30(2):57–62PubMed
5.
go back to reference Gerakis A, Hadjidakis D, Kokkinakis E, Apostolou T, Raptis S, Billis A (2000) Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol 13(6):437–443PubMed Gerakis A, Hadjidakis D, Kokkinakis E, Apostolou T, Raptis S, Billis A (2000) Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol 13(6):437–443PubMed
7.
go back to reference KDIGO (2009) Clinical practice guidelines for the management of CKD-MBD. Kidney Int 76(S113):S1–S130 KDIGO (2009) Clinical practice guidelines for the management of CKD-MBD. Kidney Int 76(S113):S1–S130
8.
9.
go back to reference Wagner J, Jhaveri KD, Rosen L, Sunday S, Mathew AT, Fishbane S (2014) Increased bone fractures among elderly United States hemodialysis patients. Nephrol Dial Transplant 29(1):146–151. doi:10.1093/ndt/gft352 PubMedCrossRef Wagner J, Jhaveri KD, Rosen L, Sunday S, Mathew AT, Fishbane S (2014) Increased bone fractures among elderly United States hemodialysis patients. Nephrol Dial Transplant 29(1):146–151. doi:10.​1093/​ndt/​gft352 PubMedCrossRef
10.
go back to reference Stehman-Breen CO, Sherrard DJ, Alem AM, Gillen DL, Heckbert SR, Wong CS, Ball A, Weiss NS (2000) Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int 58(5):2200–2205PubMedCrossRef Stehman-Breen CO, Sherrard DJ, Alem AM, Gillen DL, Heckbert SR, Wong CS, Ball A, Weiss NS (2000) Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int 58(5):2200–2205PubMedCrossRef
11.
go back to reference Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M (2001) Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2(3):165–171PubMedCrossRef Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M (2001) Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2(3):165–171PubMedCrossRef
13.
16.
go back to reference Schellinger D, Lin CS, Lim J, Hatipoglu HG, Pezzullo JC, Singer AJ (2004) Bone marrow fat and bone mineral density on proton MR spectroscopy and dual-energy X-ray absorptiometry: their ratio as a new indicator of bone weakening. AJR Am J Roentgenol 183(6):1761–1765PubMedCrossRef Schellinger D, Lin CS, Lim J, Hatipoglu HG, Pezzullo JC, Singer AJ (2004) Bone marrow fat and bone mineral density on proton MR spectroscopy and dual-energy X-ray absorptiometry: their ratio as a new indicator of bone weakening. AJR Am J Roentgenol 183(6):1761–1765PubMedCrossRef
17.
go back to reference Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476):307–310PubMedCrossRef Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476):307–310PubMedCrossRef
18.
go back to reference Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86(2):420–428PubMedCrossRef Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86(2):420–428PubMedCrossRef
20.
go back to reference Regis-Arnaud A, Guiu B, Walker PM, Krause D, Ricolfi F, Ben Salem D (2011) Bone marrow fat quantification of osteoporotic vertebral compression fractures: comparison of multi-voxel proton MR spectroscopy and chemical-shift gradient-echo MR imaging. Acta Radiol 52(9):1032–1036. doi:10.1258/ar.2011.100412 PubMedCrossRef Regis-Arnaud A, Guiu B, Walker PM, Krause D, Ricolfi F, Ben Salem D (2011) Bone marrow fat quantification of osteoporotic vertebral compression fractures: comparison of multi-voxel proton MR spectroscopy and chemical-shift gradient-echo MR imaging. Acta Radiol 52(9):1032–1036. doi:10.​1258/​ar.​2011.​100412 PubMedCrossRef
21.
go back to reference Burkhardt R, Kettner G, Bohm W, Schmidmeier M, Schlag R, Frisch B, Mallmann B, Eisenmenger W, Gilg T (1987) Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone 8(3):157–164PubMedCrossRef Burkhardt R, Kettner G, Bohm W, Schmidmeier M, Schlag R, Frisch B, Mallmann B, Eisenmenger W, Gilg T (1987) Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone 8(3):157–164PubMedCrossRef
22.
go back to reference Griffith JF, Yeung DK, Antonio GE, Lee FK, Hong AW, Wong SY, Lau EM, Leung PC (2005) Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy. Radiology 236(3):945–951. doi:10.1148/radiol.2363041425 PubMedCrossRef Griffith JF, Yeung DK, Antonio GE, Lee FK, Hong AW, Wong SY, Lau EM, Leung PC (2005) Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy. Radiology 236(3):945–951. doi:10.​1148/​radiol.​2363041425 PubMedCrossRef
23.
go back to reference Griffith JF, Yeung DK, Antonio GE, Wong SY, Kwok TC, Woo J, Leung PC (2006) Vertebral marrow fat content and diffusion and perfusion indexes in women with varying bone density: MR evaluation. Radiology 241(3):831–838. doi:10.1148/radiol.2413051858 PubMedCrossRef Griffith JF, Yeung DK, Antonio GE, Wong SY, Kwok TC, Woo J, Leung PC (2006) Vertebral marrow fat content and diffusion and perfusion indexes in women with varying bone density: MR evaluation. Radiology 241(3):831–838. doi:10.​1148/​radiol.​2413051858 PubMedCrossRef
25.
go back to reference Rosen CJ, Ackert-Bicknell C, Rodriguez JP, Pino AM (2009) Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit Rev Eukaryot Gene Expr 19(2):109–124PubMedCentralPubMedCrossRef Rosen CJ, Ackert-Bicknell C, Rodriguez JP, Pino AM (2009) Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit Rev Eukaryot Gene Expr 19(2):109–124PubMedCentralPubMedCrossRef
29.
go back to reference Nair SS, Mitani AA, Goldstein BA, Chertow GM, Lowenberg DW, Winkelmayer WC (2013) Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States. Clin J Am Soc Nephrol 8(8):1336–1342. doi:10.2215/CJN.10901012 PubMedCentralPubMedCrossRef Nair SS, Mitani AA, Goldstein BA, Chertow GM, Lowenberg DW, Winkelmayer WC (2013) Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States. Clin J Am Soc Nephrol 8(8):1336–1342. doi:10.​2215/​CJN.​10901012 PubMedCentralPubMedCrossRef
30.
go back to reference Danese MD, Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM (2006) PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 47(1):149–156PubMedCrossRef Danese MD, Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM (2006) PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 47(1):149–156PubMedCrossRef
31.
go back to reference Coco M, Rush H (2000) Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36(6):1115–1121PubMedCrossRef Coco M, Rush H (2000) Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36(6):1115–1121PubMedCrossRef
Metadata
Title
Bone marrow fat is increased in chronic kidney disease by magnetic resonance spectroscopy
Authors
R. N. Moorthi
W. Fadel
G. J. Eckert
K. Ponsler-Sipes
S. M. Moe
C. Lin
Publication date
01-06-2015
Publisher
Springer London
Published in
Osteoporosis International / Issue 6/2015
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-015-3064-7

Other articles of this Issue 6/2015

Osteoporosis International 6/2015 Go to the issue